Elevation Oncology, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol: ELEV on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 101 Federal Street, Suite 1900, Boston, MA

There are no Buy or Sell transactions made by insiders since 3/3/2024

Elevation Oncology, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Qiming U.S. Healthcare Fund II, L.P.	10%+ Owner	$1.21M			Jun 29, 2021
Vertex Global HC Fund II Pte. Ltd.	10%+ Owner	$1.18M			Jun 29, 2021
Cormorant Asset Management, LP	Former 10% Owner	$1.14M			Jun 29, 2021
venBio Global Strategic Fund III, L.P.	10%+ Owner	$972K			May 25, 2022
Joseph J. Ferra Jr	CHIEF EXECUTIVE OFFICER, Director	$320K			Feb 15, 2025
Valerie Malyvanh Jansen	Chief Medical Officer	$237K			Feb 15, 2025
David Dornan	Chief Scientific Officer	$41.5K			Feb 15, 2025
Timothy P. Clackson	Director	$24.1K			Jun 13, 2024
Tammy Furlong	Chief Financial Officer	$21.6K			Feb 15, 2025
Alan B. Sandler	Director				Jun 13, 2024
R. Michael Carruthers	Director				Jun 13, 2024
Julie M. Cherrington	Director				Jun 13, 2024
Steve Elms	Director				Jun 13, 2024
Aisling Capital IV, LP	10%+ Owner				Jun 16, 2023
Colin Walsh	Director				Jun 16, 2023
Lori Hu	Director				Jun 16, 2023
Richard Gaster	Director				Jun 24, 2021
Shawn Leland	President, CEO, Director				Feb 14, 2022
Darcy Mootz	Director				Jun 13, 2024

Showing 1 to 19 of 19 entries

Recent Insider Transactions by Companies or Individuals for Elevation Oncology, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.